Sandoz, Aurobindo Get Another Mixed Ruling in Price-Fixing Case

Aurobindo Pharma Ltd., Sandoz Inc., and other pharmaceutical companies will confront some state antitrust and consumer-protection allegations that they conspired to fix generic drug prices after a federal judge allowed certain claims to move forward while dismissing others.

Judge Michael P. Shea of the US District Court for the District of Connecticut in an April 25 order denied the companies’ motion to dismiss state-law claims brought by states including Arkansas, Florida, Colorado, Connecticut, Kentucky, and Virginia. However, he dismissed some claims brought by other states, including Rhode Island, Wisconsin, and Alaska.

The order comes after Shea made a separate ...